骨质疏松症的药物治疗进展

被引：42

作者：

李勇

季晖

机构：

[1] 中国药科大学药理学教研室,中国药科大学药理学教研室南京,南京

来源：

中国骨质疏松杂志 | 2002年 / 01期

关键词：

D O I：

暂无

中图分类号：

R58 [内分泌腺疾病及代谢病];

学科分类号：

100201 [内科学];

摘要：

引用

页数：3

共 9 条

[1]

Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: The FAVOStudy [J].

Meunier, PJ ;

Sebert, JL ;

Reginster, JY ;

Briancon, D ;

Appelboom, T ;

Netter, P ;

Loeb, G ;

Rouillon, A ;

Barry, S ;

Evreux, JC ;

Avouac, B ;

Marchandise, X .

OSTEOPOROSIS INTERNATIONAL, 1998, 8 (01) :4-12

[2]

Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.[J].C. Gennari;S. Adami;D. Agnusdei;L. Bufalino;R. Cervetti;G. Crepaldi;C. Marco;O. Munno;L. Fantasia;G. C. Isaia;G. F. Mazzuoli;S. Ortolani;M. Passed;U. Serni;L. Vecchiet.Calcified Tissue International.1997, 1

[3]

Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1–34).[J].J. F. Whitfield;P. Morley;V. Ross;R. J. Isaacs;R. H. Rixon.Calcified Tissue International.1995, 3

[4]

Effects of 1α-hydroxyvitamin D 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis.[J].H. Orimo;M. Shiraki;Y. Hayashi;T. Hoshino;T. Onaya;S. Miyazaki;H. Kurosawa;T. Nakamura;N. Ogawa.Calcified Tissue International.1994, 5

[5]

糖皮质激素诱导大鼠骨质疏松模型及依扑拉芬对其作用的影响 [J].